Journal of Clinical Oncology (JCO) Podcast

The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ

Episodes

Total: 417

The ability of an advance care planning discussion to affect end-of-life decisions is tested in a ra

The AVAPERL trial reveals a significant improvement in progression-free survival with the combinatio

This JCO Podcast provides observations and commentary on the JCO article “Osteonecrosis of the Jaw a

This podcast provides an overview and commentary on Amant et al.'s study of breast cancer diagnosed

This podcast provides observations and commentary on the JCO article,"Results of an international ra

Loss of PTEN expression did not predict resistance to trastuzumab in early stage HER2 positive breas

This podcast describes the current and future use of molecular testing, including micro RNA expressi

This podcast focuses on emerging concerns about adult outcomes in survivors of acute lymphoblastic l

This Podcast reviews the results of the analysis conducted by Metzger-Filho et al. regarding the ben

This podcast summarizes findings regarding cigarette smoking and disease-free survival in a Phase II

Response after early chemotherapy cycles might identify patients who could safely forgo consolidatio

This podcast reflects on the outcome of minimal intensity conditioning in over 1000 recipients of si

This podcast provides commentary and observations on the long term results summary of RTOG 91-11 in

This podcast reviews findings on the prevalence of off-label cancer therapy use and the estimated c

If transplantation is selected as the treatment approach, the net effect is likely to be similar wit

The fluoroquinolone class of antibiotics is a major target for antimicrobial stewardship programs, a

This podcast provides perspective on findings in a large population-based evaluation of overall surv

One third of gastric cancers harbor genetic or epigenetic alterations in the CDH1 gene, and those wi

This podcast considers the evolution, utility, and acceptability of the terms 'cancer survivor' and